Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034481

Options or other derivatives

  • Chief Medical Officer acquired 1,477,619 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Puhlmann Markus · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-12 Grant or award : show line 1 in the form Stock Options (right to buy) +1,477,619 2,885,688 D
Loading xslF345X05/rdgdoc.xml…